S6 Ep15: FDA Approval Insights: Adjuvant Pembrolizumab in RCC
Dec 6, 2021
11:57
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Dr. Choueiri discusses the significance of the FDA approval of pembrolizumab as adjuvant therapy in renal cell carcinoma and key data from the pivotal phase 3 KEYNOTE-564 trial.
